High prevalence of antiendothelial cell antibodies in migraine [1]

Headache

Volumn 42, Issue 5, 2002, Pages 385-386

  Gabrielli, Maurizio ^a,b   Santarelli, Luca ^a,b   Addolorato, Giovanni ^a,b   Foschi, Francesco Giuseppe ^a,b   Cristiana, Di Campli ^a,b   Gasbarrini, Antonio ^a,b   Fiore, Giuseppe ^a,b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VASOACTIVE AGENT;

ADULT; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LETTER; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROPATHOLOGY; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0036259529     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02114.x     Document Type: Letter

References (6)

1. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies
2. Pathogenesis of migraine
3. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
4. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
5. A need for standardization of the anti-endothelialcell antibody test
6. Antibodies to endothelial cells in systemic lupus erythe matosus: A potential marker for nephritis and vasculitis